Blood Clots, Stroke and Heart Attack Linked to Yasmin and Yaz
A study conducted on 330,000 women from Israel has revealed that women who take birth control pills that contain the hormone drospirenone, such as Yasmin and Yaz, are at an increased risk of blood clots when compared to women who take second or third generation birth control pills. This research found that the chance of developing a venous thromboembolism, a type of blood clot that develops in the veins of the legs and could move to the lungs, is 43-65 percent higher in birth control pills that contain drospirenone.
It was also discovered that eight to ten women out of every 1,000 who take a birth control pill containing drospirenone will develop a dangerous venous thromboembolism. Data released by the Food and Drug Administration (FDA) also suggests a strong link between Yaz and other birth control pills containing drospirenone and blood clots as it was discovered that these types of birth control pills can raise a woman’s risk of blood clots by 74 percent.
Yasmin and Yaz Side Effects
Yasmin and Yaz are birth control pills that are manufactured by Bayer Healthcare. Yasmin contains the standard 21 active pills while Yaz contains 24 active pills. Both of these pills contain ethinyl estradiol and drospirenone. While Bayer Healthcare claims that drospirenone is just as safe as other birth control pills, it is thought that the hormone can increase potassium levels. This can cause serious complications, particularly for women with adrenal, kidney or liver disease. Other side effects associated with Yasmin and Yaz include:
- Gallbladder disease
- Heart attack
- Pulmonary embolism
- Deep vein thrombosis
- Blood clots
- Benign liver tumors
Women with specific risk factors, including high blood pressure, diabetes or cardiovascular disease are at an increase risk of developing these complications.
FDA Investigates Blood Clots
As a result of the risk of blood clots associated with Yaz, the FDA stated that it would investigate the medication and others containing drospirenone. Research revealed that women aged 15-44 who used Yasmin, Yaz, Ocella or other birth control pills containing drospirenone were two to three times more likely to suffer a blood clot when compared to women using pills that contain levonorgestrel.
Yaz Advertising Misleading
Bayer Healthcare has been reprimanded by the FDA as a result of misleading advertisements for Yasmin and Yaz. These ads claim that the drug works for unapproved uses, including the treatment of acne and PMS symptoms. The FDA also claimed that the ads lessened the side effects that these pills can cause. As a result of misleading advertising, many women have taken Yasmin and Yaz.
Yasmin and Yaz Lawsuits
If you have suffered a stroke, heart attack or blood clot while taking Yasmin, Yaz or Ocella, you should speak with an attorney who can examine the details of your case. It has been announced that Bayer has already paid approximately $142 million in 651 cases claiming that Yasmin and Yaz cause dangerous blood clots to develop. There is still time to file a claim if you have suffered a venous thromboembolism, deep vein thrombosis or pulmonary embolism while taking Yasmin or Yaz.